Discovery and Immunologic Validation of New Antigens for Therapeutic Cancer Vaccines

Publisher： Karger

E-ISSN： 1423-0097|133|2|179-197

ISSN： 1018-2438

Source： International Archives of Allergy and Immunology, Vol.133, Iss.2, 2004-02, pp. : 179-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Discovery of chemotherapy‐associated ovarian cancer antigens by interrogating memory T cells

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 134, Iss. 8, 2014-04 ,pp. : 1823-1834

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic vaccines for prostate cancer: what have we learned?

By Gulley James L  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 3-5

Future Medicine

Access to resources Recommend Favorite

Gene Discovery in Cervical Cancer: Towards Diagnostic and Therapeutic Biomarkers

By Martin Cara M.   Kehoe Louise   Spillane Cathy O.   O'Leary John J.  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 5, 2007-01 ,pp. : 277-290

Adis International

Access to resources Recommend Favorite

Therapeutic Vaccines for Human Papillomaviruses

By  

Intervirology, Vol. 44, Iss. 2-3, 2001-08 ,pp. : 167-175

Karger

Access to resources Recommend Favorite

Validation of histone deacetylase 3 as a therapeutic target in castration‐resistant prostate cancer

By  

THE PROSTATE, Vol. 78, Iss. 4, 2018-03 ,pp. : 266-277

John Wiley & Sons Inc

Access to resources Recommend Favorite